RNS

06:39 Thu 25 May 2017

Rex Bionics PLC - Holdings in Company

RNS Number : 2341G

Rex Bionics PLC

25 May 2017

For filings with the FCA include the annex
For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ⁱⁱ		REX BIONICS PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			ü
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: ⁱⁱⁱ	DHRUPA PATEL
4. Full name of shareholder(s) (if different from 3.):^iv	MARK BRADSHAW
5. Date of the transaction and date on which the threshold is crossed or reached: ^v	23^rd MAY, 2017
6. Date on which issuer notified:	23^rd MAY, 2017
7. Threshold(s) that is/are crossed or reached: ^{vi, vii}	12%

8. Notified details:

A: Voting rights attached to shares ^{viii, ix}

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights ^x

Direct

Direct ^xi

Indirect ^xii

Direct

Indirect

GB00BLRLQM66

3,172,450

12.43%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date ^xiii

Exercise/
Conversion Period ^xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date ^xvii

Exercise/
Conversion period ^xviii

Number of voting rights instrument refers to

% of voting rights ^{xix, xx}

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,172,450

12.43%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ^xxi
Mark Bradshaw controls 3,172,450 shares and 1,420,887 shares via Bradshaw Asset Management Limited directly. Bradshaw Asset Management is also investment advisor to Victory Special Opportunities Fund, a cell of Freedom Global Funds PLC which owns 477,778 shares and 100,000 Warrants issued on 1^st August 2016.

Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A

13. Additional information:
14. Contact name:	DHRUPA PATEL
15. Contact telephone number:	0207 250 4350

Note: Annex should only be submitted to the FCA not the issuer
Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	MARK BRADSHAW
Contact address (registered office for legal entities)	10-11 CHARTERHOUSE SQUARE LONDON EC1M 6EE
Phone number & email	0207 250 4350 [email protected]
Other useful information (at least legal representative for legal persons)

B: Identity of the notifier, if applicable
Full name	DHRUPA PATEL
Contact address	10-11 CHARTERHOUSE SQUARE LONDON EC1M 6EE
Phone number & email	0207 250 4350 [email protected]
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	COMPLIANCE OFFICER BRADSHAW ASSET MANAGEMENT

C: Additional information

For notes on how to complete form TR-1 please see the FCA website.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLLIFVAETIEFID

Quick facts: Rex Bionics PLC

Price: -

Market: AIM

Market Cap: -

Follow

View company profile

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE